|
Published by: Kalorama Information
Published: Aug. 1, 2001 - 450 Pages Now 25% off original price of $3250.
Table of Contents
Foreward
- Objectives
- Target Audience
- Scope and Content of Report
- Methodology
1. Executive Summary and Introduction
- Executive Summary
- Tissue Engineering Industry Overview
- Products on the Market
- Market Forecasts and Market Share
- Tissue Engineering Demographics
- Tissue Engineering Industry
- Size of the Potential Engineered Tissue Market
- Sales of FDA-Approved Tissue Engineering Products
- Challenges Facing the Tissue Engineering Industry
- Market Estimates
- Market Trends
- Market Forecast
- International Tissue Engineering Activity
- Novel Bioreactor Design—Europe Following U.S. Lead
- Tissue Engineering Companies and Organizations
- Trends in Company Activities
- Investment Trends
- Strategic Issues in Tissue Engineering
- Key Factors in Future Development
- Standards Development in the U.S.
- Introduction
- Tissue Engineering Essentials
- A Natural Form of Medicine
- A Fast-Growing Industry
- Tissue Engineering Techniques
- Regenerative Biology
- The Potential for Tissue Engineering
- Developmental Biology and Functional Genomics
- Contributions by MIT and Harvard
- Challenges in Tissue Engineering
- Tissue Engineering Industry Overview
- Defining Tissue Engineering
- Regenerative Medicine
- Excluded Technologies
- Classification of Technologies
- In Vitro Tissue Engineering
- Tissue Engineering Process Components
- Tissue Engineering: An Historical Perspective
2. Demographics: Description of Industry,
Potential Disease Modalities
- Tissue Engineering Technologies
- Potential Disease Modalities
- Skin Tissues
- Skin Therapies
- Autografts vs. Allografts
- Natural Skin Wound Healing
- Skin Replacements
- Skin Transplantation: Autograft
- Skin Transplantation: Allograft
- Tissue engineered Skin Products
- Decellularized Skin
- Skin Substitutes: Autologous Cells
- Skin Substitutes: Allogeneic Cells
- Indications
- Bone Tissues
- Clinical Orthopedics
- Orthopedic Tissue-Basic Biology
- Synthetic Bone Grafts
- Cartilage Tissues
- Articular Cartilage
- Repairing Meniscus Cartilage
- Hyaluronase Polymers (Synvisc®, Hyalgan®)
- Advances in Cartilage Technology
- Companies Involved in Cartilage Tissue Engineering
- Circulatory—Heart Muscles, Veins
- Heart Attacks
- Vascular Arterial Damage
- Stroke
- Coronary Vascular Graft
- Muscle Tissue Engineering for Cardiac Patch
- Biomaterials for Mechanical Heart Valve Prostheses
- Bladder and Urinary Tract
- Controlling Urine Flow
- Treatments
- Tissue Engineered Bulking
- Bladder Augmentation
- Clinical Challenges in the Genitourinary System
- Tissue Engineering—Diagnostic and Toxicology Applications
- Toxicity Testing
- Battlefield Threats
- Tissue-Based Biosensors
- Tissue Culture Systems
- Liver
- Liver Assist Devices
- Current Liver Therapies
- Research
- Liver Research in Japan
- Pancreas
- Functional Genomics and Developmental Biology Platforms
- Islet Cell Transplantation
- Definitions
- Potential Problems With the Bio-Artificial Pancreas
- Islet Sheet
- Use of Bioartificial Pancreas
- Other Engineered Tissues—Oral Tissues
- Soft Oral Tissue—Saliva Glands
- Soft Tissue and Salivary Glands
- Development of Artificial Salivary Glands
- Other Engineered Tissues--Muscle
- Other--Spinal Cord, Nerves
- Areas of Research
- Promoting Nervous System Regeneration
- Scaffolds for Neural Tissue Engineering
- Neural Stem Cell Regeneration
3. Products on the Market and in Clinical Development
- Background
- Products in Development
- Skin—First Tissue Engineered Products
- Tissue Engineered Cartilage Products
- The First Tissue Engineered Organs
- Tissue Information and the Material Interface
- Products in the Pipeline or at the Bedside
- Company Involvement in Product Research and Development
- Bone/Soft Tissue Repair and Synthetic Bone Substitutes
- Bone/Soft Tissue Repair Biologic Products, Allograft
- Bone/Soft Tissue Repair Biologic Products, Chondrocyte Transplantation
- Bone/Soft Tissue Repair, Growth Factors/Osteoinductives
- Bone/Soft Tissue Repair, Bovine
- Bone/Soft Tissue Repair Soft Tissue Repair/Replacement
- Potential for Gene Therapy Products
- Potential for Stem Cell Therapy Products
- Bone Substitute Sources
4. Market Forecasts and Market Share
- Tissue Engineering Industry
- Tissue Engineering Demographics
- Tissue Engineering Industry General Trends
- Size of the Potential Engineered Tissue Market
- Where Will the First Products Be?
- Sales of FDA-Approved Tissue Engineering Products
- Challenges Facing the Tissue Engineering Industry
- Funding Alternatives
- Challenges Due to Regulatory Issues
- Staffing Issues Impacting Commercial Success
- Education Issues Impacting Commercial Success
- Market Estimates
- Market Trends
- Too Many Companies Researching the Same Product Areas
- Biotechnology Industry Overview
- Market Opportunities: Autograft vs Allograft
- Market Forecast—Skin
- Wound Care
- Burns, Skin—Acute Care
- Ulcers, Skin—Chronic Care
- Market Forecast—Cartilage
- Market Forecast—Bone
- Market Forecast—Cardiovascular
- Tissue Engineered Small Diameter Blood Vessels
- Stroke
- Market Forecast—Liver Disease
- Market Forecast—Diabetes
- Market Forecast—Oral Mucosa
- Market Forecast—Diagnostics and Toxicology Testing
5. International Tissue Engineering Activity
1) Differences in Funding Sources
2) Autologous vs. Allogeneic Cell Usage
3) Cell Technology Advances in Europe and Japan
4) Cross Disciplinary Environments—Linking Basic
Biology and Materials Sciences
5) Genomics and Informatics
6) Novel Bioreactor Design—Europe Following U.S. Lead
- International Markets and Activities
- Europe
- Selected German Tissue Engineering Organizations
- Selected United Kingdom Tissue Engineering Organizations
- Selected Swiss Tissue Engineering Organizations
- Selected French Tissue Engineering Organizations
- Selected Dutch Tissue Engineering Organizations
- Japan
6. Overview of Tissue Engineering Companies and Organizations
- Commercial Organizations
- Trends in Company Activities
- Advanced Tissue Sciences, Inc.
- Anika Therapeutics, Inc.
- Biora AB
- BioTissue Technologies, AG.
- Chondros, Inc.
- Circe Biomedical, Inc.
- Co.don AG
- Collagenesis, Inc.
- Curis, Inc.
- Encelle, Inc.
- ETEX, Corp.
- Fibrogen, Inc.
- GenSci Regeneration Sciences, Inc.
- Genzyme Biosurgery, Inc.
- Innogenetics, NV
- Integra LifeSciences Corp.
- IsoTis NV
- Isto Technologies, Inc.
- LifeCell Corporation
- Modex Therapeutics, Ltd.
- Organogenesis, Inc.
- Ortec International, Inc.
- Protein Polymer Technology, Inc.
- Tutogen Medical, Inc.
- Academic Organizations and Associations in Tissue Engineering
- BioMedical Engineering Departments and Programs at U.S. and
- Canadian Universities
- Government Activities and Interests
- Relationship to Agency Mission
- Synergies
- Funding
- Federal Agency Activities
- Other Companies, Enabling Technologies
7. Strategic Issues in Tissue Engineering
- Competition
- Skin Product Competitors
- Bone
- Liver: Hepatic Diseases, Liver Assist Devices
- Cartilage
- Pancreas
- Enabling Technologies
- Regulatory
- Agencies
- Guidelines
- FDA Market Approvals
- Cost of Additional Regulations
- Tissue Regulation
- Process for Drug and Biologics Approvals
- Cellular-Based Products
- Funding to Survive Clinical Trials
- Regulatory Issues in Europe and Japan
- Reimbursement
- Emerging Technologies
- Tissue Engineering Technology
- Role of Academic Institutions
- Key Strategies: Development of Product Platform Technologies
- Key Factors in Future Development
- Bioreactors
- Cell Types Used in Tissue Engineering
- Microscopy
- Use of Tissue Engineered Products in Toxicology and Diagnostics
- Tissue Engineering Technological Challenges
- Standards Development
- Standards Development in the U.S.
- World-Wide Standards Development
- Performance Standards
- International Standards Activities
- Standards for Biomaterials
- Industry Social and Political Aspects
- Tissue Engineering and Cloning
- Private Sector Cloning
- Xenotransplantation
8. Summary and Conclusions
- Future of Tissue Engineering
- Industry Opportunities
- Wound Healing, Orthopedics
- Vascularization
- Bioreactors
- Informatics and Tissue Engineering
- Dental Markets
- Marketing Opportunities: Acute (Allogeneic) vs.
- Chronic (Autologous) Markets
- Industry Challenges
- Time to Market
- Lack of Commercial Successes—Funding Issues
- Need for Tissue Engineers
- Academic Activities
- Government Support
- Technical Challenges
- Regulatory Challenges
- Tissue Engineering Trends
- General Tissue Engineering Industry Trends
- Trends in Biomaterials
- International Trends
- General Biotechnology Industry Trends
- Healthcare Trends
Appendix: Tissue Engineering Websites and Links
List of Exhibits
Table 1-1: Components of Regenerative Medicine
Table 1-2: Tissue Engineered Medical Products
Table 2-1: Advantages and Disadvantages of Various Bone Therapies
Table 2-2: Comparison of Cartilage Therapies
Table 3-1: Tissue Engineering Products in the Pipeline
or Currently Marketed
Table 3-2: Commercially Available Bone Substitutes For Orthopedic
Reconstruction
Table 4-1: Growth of Tissue Engineering in the U.S.
Table 4-2: Tissue Engineering Statistics
Table 4-3: Type of Transplant
Table 4-4: Incidence of Organ and Tissue Deficiencies in the
U.S. Indication, Procedures or Patients/Year
Table 4-5: Burns U.S. Annually
Table 4-6: Burns Worldwide Annually
Table 4-7: Chronic Skin Wound Care Market Estimates
Table 4-8: Cartilage Markets
Table 4-9: Bone Repair and Implant Markets
Table 4-10: Market Estimates, Vascular Arterial Damage
Table 4-11: Diabetics Prevalence, 1995
Table 4-12: Cases of Oral Mucosa Replacement Therapy
Table 5-1: Selected European, Japanese and Australian Organizations
Involved in Tissue Engineering Research and Development
Table 5-2: Comparisons Among U.S., Japanese, and European
Tissue Engineering Research and Development
Table 6-1: Biomedical Engineering Departments and Programs
at U.S. and Canadian Universities
Table 6-2: Participating Mates Agencies
Table 6-3: NIST/ATP Extramural Awards in Tissue Engineering
Competition, (1991-2000)
Table 6-4: NOST/ATP Awards in Tissue Engineering (1991 - 2000) -
Extramural
Table 6-5: Atp Awards in Tissue Engineering (1991-2000)
Table 7-1: Skin Competitors
Table 7-2: Other Organizations With Skin Technologies or
Capabilities of Developing Skin Products
Table 7-3: Competitive Activities in Bone Technology
AbstractFew areas of study and development receive as much attention in both the scientific and lay press as Tissue Engineering. This comprehensive report from Kalorama Information examines current products (including features and benefits) and products under development including:
- Isolated cells used for implantation
- Cells combined with biomaterials and active substances
- Biomaterial based scaffolds
- Administration of active substances to affect endogenous tissue
In addition, key technologies used in research as well as scientific and social issues will be presented and discussed.
Market forecasts and shares will be presented for existing products and estimates for new product entries will be presented and will include any type or level of product displacement.
Over 70 companies will be presented who are either existing suppliers and/or have active R&D programs.
Get Full Details About This Report >>
|
